Clinical Trial Update: Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating netarsudil for accelerating corneal endothelial restoration in Fuchs' endothelial dystrophy was terminated with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Endothelial Dystrophy

Drugs mentioned

• Netarsudil (netarsudil)

Snippet

Sponsor: Price Vision Group | Conditions: Fuchs' Endothelial Dystrophy | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-02-06